Your browser doesn't support javascript.
loading
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
Di Stefano, Leon; Ogburn, Elizabeth L; Ram, Malathi; Scharfstein, Daniel O; Li, Tianjing; Khanal, Preeti; Baksh, Sheriza N; McBee, Nichol; Gruber, Joshua; Gildea, Marianne R; Clark, Megan R; Goldenberg, Neil A; Bennani, Yussef; Brown, Samuel M; Buckel, Whitney R; Clement, Meredith E; Mulligan, Mark J; O'Halloran, Jane A; Rauseo, Adriana M; Self, Wesley H; Semler, Matthew W; Seto, Todd; Stout, Jason E; Ulrich, Robert J; Victory, Jennifer; Bierer, Barbara E; Hanley, Daniel F; Freilich, Daniel.
Afiliação
  • Di Stefano L; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Ogburn EL; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Ram M; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Scharfstein DO; Division of Brain Injury Outcomes, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Li T; Division of Biostatistics, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Khanal P; University of Colorado Denver, Anschutz Medical Campus, Denver, Colorado, United States of America.
  • Baksh SN; Division of Brain Injury Outcomes, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • McBee N; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Gruber J; Division of Brain Injury Outcomes, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Gildea MR; Division of Brain Injury Outcomes, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Clark MR; Division of Brain Injury Outcomes, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Goldenberg NA; Division of Brain Injury Outcomes, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Bennani Y; Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Brown SM; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
  • Buckel WR; Johns Hopkins All Children's Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States of America.
  • Clement ME; Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Mulligan MJ; University Medical Center, New Orleans, New Orleans, Louisiana, United States of America.
  • O'Halloran JA; Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, Utah, United States of America.
  • Rauseo AM; University of Utah, Salt Lake City, Utah, United States of America.
  • Self WH; Pharmacy Services, Intermountain Healthcare, Murray, Utah, United States of America.
  • Semler MW; Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Seto T; University Medical Center, New Orleans, New Orleans, Louisiana, United States of America.
  • Stout JE; Department of Medicine, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, New York, United States of America.
  • Ulrich RJ; Vaccine Center, New York University Grossman School of Medicine, New York, New York, United States of America.
  • Victory J; Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, United States of America.
  • Bierer BE; Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, United States of America.
  • Hanley DF; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Freilich D; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
PLoS One ; 17(9): e0273526, 2022.
Article em En | MEDLINE | ID: mdl-36173983

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Idioma: En Ano de publicação: 2022 Tipo de documento: Article